Literature DB >> 27855398

Lower Bmi-1 Expression May Predict Longer Survival of Colon Cancer Patients.

Xiaodong Li1, Xiao Zheng, Bin Xu, Dachuan Zhang, Yun Xu, Quanqin Xie, Wenwei Hu, Zhuojun Zheng, Yingjie Shao, Jun Wu, Mei Ji, Jingting Jiang, Changping Wu.   

Abstract

BACKGROUND: This study aimed to investigate the Bmi-1 expression and the clinical significance in colon cancer (CC). PATIENTS AND METHODS: Bmi-1 expression in tumor tissue and the corresponding normal tissue was detected using immunohistological staining. The correlations between Bmi-1 expression and clinicopathological characteristics and the overall survival (OS) time were analyzed.
RESULTS: The median H-scores of Bmi-1 in CC tissues and the corresponding tissues were 80.0 (0-270) and 5.0 (0-90), with no statistically significant difference (Z=-13.7, P<0.001). Bmi-1 expression in CC tissues was not statistically correlated with any characteristics. The median OS times for CC patients with high or low Bmi-1 expression were 53.7 months and 44.9 months, respectively, with no statistically significant difference (P = 0.123). The survival rates of patients with low Bmi-1 expression were higher than those of patients with high Bmi-1 expression but the differences were not statistically significant.
CONCLUSION: Bmi-1 expression in CC tissue is significantly higher than that in corresponding normal tissue. While there may be a trend towards improved survival, this is not statistically significant.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27855398     DOI: 10.1159/000452510

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-Mediated Antitumor Agents.

Authors:  Lian-Fang Yang; Yajing Xing; Jie-Xin Xiao; Jia Xie; Wei Gao; Jiuqing Xie; Li-Ting Wang; Jinhua Wang; Mingyao Liu; Zhengfang Yi; Wen-Wei Qiu
Journal:  ACS Med Chem Lett       Date:  2018-09-27       Impact factor: 4.345

2.  Impact of BMI1 expression on the apoptotic effect of paclitaxel in colorectal cancer.

Authors:  Hsiang-Lin Tsai; Shin-Yu Pang; Hui-Ching Wang; Chi-Wen Luo; Qiao-Lin Li; Tzu-Yi Chen; Shao-Yu Fang; Jaw-Yuan Wang; Mei-Ren Pan
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

3.  CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer.

Authors:  Changpeng Hu; Qian Zhang; Qin Tang; Huyue Zhou; Wuyi Liu; Jingbin Huang; Yali Liu; Qin Wang; Jing Zhang; Min Zhou; Fangfang Sheng; Wenjing Lai; Jing Tian; Guobing Li; Rong Zhang
Journal:  J Cell Mol Med       Date:  2019-11-13       Impact factor: 5.310

4.  A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.

Authors:  Jinhua Wang; Yajing Xing; Yingying Wang; Yundong He; Liting Wang; Shihong Peng; Lianfang Yang; Jiuqing Xie; Xiaotao Li; Wenwei Qiu; Zhengfang Yi; Mingyao Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-10-22

5.  Clinicopathological and Prognostic Significance of Expression of B-Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (BMI-1) Gene and Protein in Gastrointestinal Stromal Tumors.

Authors:  Kun Zhu; Kang Li; Da-Wei Yuan; Gang Xu; Li Kang; Cheng-Xue Dang; Yong Zhang
Journal:  Med Sci Monit       Date:  2018-09-13

Review 6.  Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.

Authors:  Christine Koulis; Raymond Yap; Rebekah Engel; Thierry Jardé; Simon Wilkins; Gemma Solon; Jeremy D Shapiro; Helen Abud; Paul McMurrick
Journal:  Cancers (Basel)       Date:  2020-03-28       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.